Concepedia

Increased uptake and new therapies are needed to avert rising hepatitis C-related end stage liver disease in England: Modelling the predicted impact of treatment under different scenarios

Ross Harris, Brenda Thomas, Jade Griffiths, A Costella, Ruth Chapman, Mary Ramsay, Daniela De Angelis, H Harris

Journal of Hepatology · 2014 · 79 citations · 24 references

DOIFull text

Open access

References

24

Boceprevir for Untreated Chronic HCV Genotype 1 Infection

Fred Poordad, Jonathan McCone, Bruce R. Bacon et al. · New England Journal of Medicine · 2011 · 2.5K citations · Full text

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

Ira M. Jacobson, John G. McHutchison, Geoffrey Dusheiko et al. · New England Journal of Medicine · 2011 · 2.4K citations · Full text

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

Paul Y. Kwo, Eric Lawitz, Jonathan McCone et al. · The Lancet · 2010 · 703 citations · Full text

, , +10

State-Transition Modeling

Uwe Siebert, Oğuzhan Alagöz, Ahmed M. Bayoumi et al. · Medical Decision Making · 2012 · 333 citations

, , +13

Cost–Effectiveness of Hepatitis C Virus Antiviral Treatment for Injection Drug User Populations

Natasha K. Martin, Peter Vickerman, Alec Miners et al. · Hepatology · 2011 · 221 citations · Full text